Maternal nutrition intervention and maternal complications in 4 districts of Bangladesh: A nested cross-sectional study.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
10 2019
Historique:
received: 18 03 2019
accepted: 30 08 2019
entrez: 5 10 2019
pubmed: 5 10 2019
medline: 6 2 2020
Statut: epublish

Résumé

Maternal morbidity is common in Bangladesh, where the maternal mortality rate has plateaued over the last 6 years. Maternal undernutrition and micronutrient deficiencies contribute to morbidity, but few interventions have measured maternal outcomes. We compared reported prevalence of antepartum, intrapartum, and postpartum complications among recently delivered women between maternal nutrition intervention and control areas in Bangladesh. We conducted a cross-sectional assessment nested within a population-based cluster-randomized trial comparing a nutrition counseling and micronutrient supplement intervention integrated within a structured home-based maternal, newborn, and child health (MNCH) program to the MNCH program alone in 10 sub-districts each across 4 Bangladesh districts. Eligible consenting women, delivering within 42-60 days of enrollment and identified by community-level health workers, completed an interviewer-administered questionnaire detailing the index pregnancy and delivery and allowed review of their home-based care register. We compared pooled and specific reported antepartum, intrapartum, and postpartum complications between study groups using hierarchical logistic regression. There were 594 women in the intervention group and 506 in the control group; overall, mean age was 24 years, 31% were primiparas, and 39% reported facility-based delivery, with no significant difference by study group. There were no significant differences between the intervention and control groups in household-level characteristics, including reported mean monthly income (intervention, 6,552 taka, versus control, 6,017 taka; p = 0.48), having electricity (69.6% versus 71.4%, p = 0.84), and television ownership (41.1% versus 38.7%, p = 0.81). Women in the intervention group had higher recorded iron and folic acid and calcium supplement consumption and mean dietary diversity scores, but reported anemia rates were similar between the 2 groups (5.7%, intervention; 6.5%, control; p = 0.83). Reported antepartum (69.4%, intervention; 79.2%, control; p = 0.12) and intrapartum (41.4%, intervention; 48.5%, control; p = 0.18) complication rates were high and not significantly different between groups. Reported postpartum complications were significantly lower among women in the intervention group than the control group (33.5% versus 48.2%, p = 0.02), and this difference persisted in adjusted analysis (adjusted odds ratio [AOR] = 0.51, 95% CI 0.32-0.82; p < 0.001). For specific conditions, odds of retained placenta (AOR = 0.35, 95% CI 0.19-0.67; p = 0.001), postpartum bleeding (AOR = 0.37, 95% CI 0.15-0.92; p = 0.033), and postpartum fever/infection (AOR = 0.27, 95% CI 0.11-0.65; p = 0.001) were significantly lower in the intervention group in adjusted analysis. There were no significant differences in reported hospitalization for antepartum (49.8% versus 45.1%, p = 0.37), intrapartum (69.9% versus 59.8%, p = 0.18), or postpartum (36.1% versus 29.9%, p = 0.49) complications between the intervention and control groups. The main limitations of this study are outcome measures based on participant report, non-probabilistic selection of community-level workers' catchment areas for sampling, some missing data for variables derived from secondary sources (e.g., dietary diversity score), and possible recall bias for reported dietary intake and supplement use. Reported overall postpartum and specific intrapartum and postpartum complications were significantly lower for women in intervention areas than control areas, despite similar rates of facility-based delivery and hospitalization for reported complications, in this exploratory analysis. Maternal nutrition interventions providing intensive counseling and micronutrient supplements may reduce some pregnancy complications or impact women's ability to accurately recognize complications, but more rigorous evaluation is needed for these outcomes.

Sections du résumé

BACKGROUND
Maternal morbidity is common in Bangladesh, where the maternal mortality rate has plateaued over the last 6 years. Maternal undernutrition and micronutrient deficiencies contribute to morbidity, but few interventions have measured maternal outcomes. We compared reported prevalence of antepartum, intrapartum, and postpartum complications among recently delivered women between maternal nutrition intervention and control areas in Bangladesh.
METHODS AND FINDINGS
We conducted a cross-sectional assessment nested within a population-based cluster-randomized trial comparing a nutrition counseling and micronutrient supplement intervention integrated within a structured home-based maternal, newborn, and child health (MNCH) program to the MNCH program alone in 10 sub-districts each across 4 Bangladesh districts. Eligible consenting women, delivering within 42-60 days of enrollment and identified by community-level health workers, completed an interviewer-administered questionnaire detailing the index pregnancy and delivery and allowed review of their home-based care register. We compared pooled and specific reported antepartum, intrapartum, and postpartum complications between study groups using hierarchical logistic regression. There were 594 women in the intervention group and 506 in the control group; overall, mean age was 24 years, 31% were primiparas, and 39% reported facility-based delivery, with no significant difference by study group. There were no significant differences between the intervention and control groups in household-level characteristics, including reported mean monthly income (intervention, 6,552 taka, versus control, 6,017 taka; p = 0.48), having electricity (69.6% versus 71.4%, p = 0.84), and television ownership (41.1% versus 38.7%, p = 0.81). Women in the intervention group had higher recorded iron and folic acid and calcium supplement consumption and mean dietary diversity scores, but reported anemia rates were similar between the 2 groups (5.7%, intervention; 6.5%, control; p = 0.83). Reported antepartum (69.4%, intervention; 79.2%, control; p = 0.12) and intrapartum (41.4%, intervention; 48.5%, control; p = 0.18) complication rates were high and not significantly different between groups. Reported postpartum complications were significantly lower among women in the intervention group than the control group (33.5% versus 48.2%, p = 0.02), and this difference persisted in adjusted analysis (adjusted odds ratio [AOR] = 0.51, 95% CI 0.32-0.82; p < 0.001). For specific conditions, odds of retained placenta (AOR = 0.35, 95% CI 0.19-0.67; p = 0.001), postpartum bleeding (AOR = 0.37, 95% CI 0.15-0.92; p = 0.033), and postpartum fever/infection (AOR = 0.27, 95% CI 0.11-0.65; p = 0.001) were significantly lower in the intervention group in adjusted analysis. There were no significant differences in reported hospitalization for antepartum (49.8% versus 45.1%, p = 0.37), intrapartum (69.9% versus 59.8%, p = 0.18), or postpartum (36.1% versus 29.9%, p = 0.49) complications between the intervention and control groups. The main limitations of this study are outcome measures based on participant report, non-probabilistic selection of community-level workers' catchment areas for sampling, some missing data for variables derived from secondary sources (e.g., dietary diversity score), and possible recall bias for reported dietary intake and supplement use.
CONCLUSIONS
Reported overall postpartum and specific intrapartum and postpartum complications were significantly lower for women in intervention areas than control areas, despite similar rates of facility-based delivery and hospitalization for reported complications, in this exploratory analysis. Maternal nutrition interventions providing intensive counseling and micronutrient supplements may reduce some pregnancy complications or impact women's ability to accurately recognize complications, but more rigorous evaluation is needed for these outcomes.

Identifiants

pubmed: 31584939
doi: 10.1371/journal.pmed.1002927
pii: PMEDICINE-D-19-01044
pmc: PMC6777761
doi:

Substances chimiques

Micronutrients 0

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1002927

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Acta Paediatr. 2017 Jan;106(1):49-54
pubmed: 27659772
Int J Gynaecol Obstet. 2009 Jul;106(1):3-7
pubmed: 19368922
J Health Popul Nutr. 2008 Jun;26(2):232-40
pubmed: 18686556
Cochrane Database Syst Rev. 2015 Oct 27;(10):CD008666
pubmed: 26503498
Lancet Glob Health. 2014 Jun;2(6):e323-33
pubmed: 25103301
Reproduction. 2018 Sep;156(3):R69-R82
pubmed: 29844225
Curr Opin Clin Nutr Metab Care. 2017 May;20(3):204-210
pubmed: 28207425
Cochrane Database Syst Rev. 2018 Oct 01;10:CD001059
pubmed: 30277579
Int J Epidemiol. 2015 Dec;44(6):1862-76
pubmed: 26275453
Cochrane Database Syst Rev. 2015 Feb 02;(2):CD000230
pubmed: 25927101
Lancet Glob Health. 2018 Dec;6(12):e1297-e1308
pubmed: 30361107
Matern Child Nutr. 2018 Oct;14(4):e12613
pubmed: 29656488
Cochrane Database Syst Rev. 2015 Jul 22;(7):CD004736
pubmed: 26198451
Lancet. 2013 Aug 3;382(9890):427-451
pubmed: 23746772
PLoS One. 2016 Sep 01;11(9):e0161647
pubmed: 27583478
Semin Perinatol. 2015 Aug;39(5):361-72
pubmed: 26166560
Public Health. 2008 Feb;122(2):161-72
pubmed: 17826810
JAMA. 2015 Dec 1;314(21):2263-70
pubmed: 26624825
BMC Pregnancy Childbirth. 2014 Oct 04;14:347
pubmed: 25282340
Am J Clin Nutr. 2017 Jul;106(1):77-87
pubmed: 28490513
J Nutr. 2018 Aug 1;148(8):1352-1363
pubmed: 29931108
J Nutr. 2018 May 1;148(5):790-797
pubmed: 30053285
J Nutr. 2017 Dec;147(12):2326-2337
pubmed: 29021370
Am J Epidemiol. 2000 Sep 15;152(6):542-7
pubmed: 10997544
J Nutr. 2019 Jan 1;149(1):159-166
pubmed: 30649523
J Endocrinol. 2018 Feb;236(2):R93-R103
pubmed: 29109081
Popul Stud (Camb). 2014;68(2):217-36
pubmed: 24134511
J Health Popul Nutr. 2001 Sep;19(3):S217-64
pubmed: 11761778
Nutrients. 2017 Jan 10;9(1):null
pubmed: 28075369
J Nutr. 2016 Oct;146(10):2075-2084
pubmed: 27581575
Matern Child Nutr. 2016 May;12 Suppl 1:141-54
pubmed: 27187912
Cochrane Database Syst Rev. 2017 Mar 05;3:CD011761
pubmed: 28260263
Bull World Health Organ. 2016 May 1;94(5):351-61
pubmed: 27147765
Nutrients. 2012 Mar;4(3):208-30
pubmed: 22666547
Cochrane Database Syst Rev. 2013 Mar 28;(3):CD006896
pubmed: 23543547
Reprod Health. 2018 Jun 22;15(Suppl 1):98
pubmed: 29945657

Auteurs

Catherine S Todd (CS)

Global Health, Population, and Nutrition, FHI 360, Durham, North Carolina, United States of America.

Zakaria Chowdhury (Z)

Alive & Thrive Program Office, Dhaka, Bangladesh.

Zeba Mahmud (Z)

Alive & Thrive Program Office, Dhaka, Bangladesh.

Sadia Shabnam (S)

BRAC, Dhaka, Bangladesh.

Musarrat Parvin (M)

Alive & Thrive Program Office, Dhaka, Bangladesh.

Alissa Bernholc (A)

Global Health, Population, and Nutrition, FHI 360, Durham, North Carolina, United States of America.

Andres Martinez (A)

Global Health, Population, and Nutrition, FHI 360, Durham, North Carolina, United States of America.

Bachera Aktar (B)

BRAC James P. Grant School of Public Health, BRAC University, Dhaka, Bangladesh.

Kaosar Afsana (K)

BRAC James P. Grant School of Public Health, BRAC University, Dhaka, Bangladesh.

Tina Sanghvi (T)

Alive & Thrive Headquarters Office, Washington, District of Columbia, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH